Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management. [PDF]
Faraj CA, McCutcheon IE.
europepmc +1 more source
Malignant melanoma is a devastating disease with a 5-year survival rate of approximately 20%. At the time of diagnosis, approximately 4% of patients had metastatic disease and between 5% and 20% had brain metastases.
Diana P. Duarte-Mora +2 more
doaj
Safety and effectiveness of stereotactic radiosurgery for larger hemangioblastomas (>2cc): A multi-center retrospective study. [PDF]
Pichardo-Rojas PS +43 more
europepmc +1 more source
Salvage microsurgery for vestibular schwannoma after failed stereotactic radiosurgery: a multi-institutional retrospective study. [PDF]
Friso F +22 more
europepmc +1 more source
Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma. [PDF]
Skeie BS +16 more
europepmc +1 more source
Patterns of failure following stereotactic radiosurgery salvage for recurrent high-grade glioma. [PDF]
Bindal S +9 more
europepmc +1 more source
Stereotactic radiosurgery for NF2-related schwannomatosis and schwannomatosis-associated spinal tumors: a single-institution cohort. [PDF]
Sanker V +9 more
europepmc +1 more source
Resection of brain radionecrosis after stereotactic radiosurgery or radiotherapy: a meta-analysis. [PDF]
Donthineni K +8 more
europepmc +1 more source
Erratum: Global Growth and Distribution of CyberKnife Stereotactic Radiosurgery: A Bibliometric Analysis: Corrigendum. [PDF]
Annagiri S +8 more
europepmc +1 more source

